![]() |
West Virginia |
PROTOCOL:
![]() |
Public Health Action
Disease Control Objectives
Disease Prevention Objectives
Disease Surveillance Objectives
Public Health SignificanceStaphylococcus aureus is uniquely adapted to cause disease in humans. The reservoir for the bacteria is the anterior nares in humans; 40% of people are colonized with Staphylococcus at any given time. Colonization means that the bacteria is carried in the body without causing illness. Many individuals are persistently colonized (estimated half-life of colonization is 40 months); others are intermittently colonized. Many who are nasally colonized also carry the organism on their hands, and this likely represents the major mode of transmission from one person to another. Nosocomial transmission of Staphylococcus aureus occurs primarily via the hands of health care workers. Rates of staphylococcal colonization and infection are increased in persons with diabetes, patients on dialysis (hemodialysis or peritoneal dialysis), injecting drug users and others with disturbances of skin integrity (e.g., burns, indwelling lines, etc.). Persons with human immunodeficiency virus infection are also at increased risk for colonization and infection with Staphylococcus. Staphylococci can also survive dessication for days to weeks, and can travel great distances through the air. Nasal carriers and patients with burns can shed large numbers of organisms into the air. It is uncertain to what extent aerial dissemination plays a role in transmission. While colonization obviously does not result in infection in most persons, infections with Staphylococcus can be life-threatening. The organism is virulent and invasive. Sepsis can result in rapid multi-organ failure and death. Deep-seated infections in bones or soft tissue can occur anywhere in the body, and are extremely difficult to treat, requiring weeks of antibiotics. In addition to these characteristics, Staphylococcus aureus has developed resistance to almost every antibiotic ever used to treat it. By the late 1950's, almost 50% of all strains were resistant to penicillin. In 1960, methicillin – a penicillinase-resistant beta-lactam – was discovered to be effective in treatment of Staphylococcus. Methicillin-resistant strains of staphylococci emerged in the late 1970's, and have added enormously to the expense of modern hospital care because of the money required to treat and isolate patients infected with this organism. Once only found in tertiary medical care centers, MRSA subsequently spread to nursing homes and smaller community hospitals. In the last few years, MRSA has even been identified as a cause of community-acquired infection in previously healthy children, with a few resultant deaths. Unfortunately, MRSA has maintained the virulence of the native organism. There is no difference in mortality among hospitalized inpatients with MRSA and methicillin-sensitive Staphylococcus aureus. Vancomycin intermediate resistant Staphylococcus aureus was first identified in Japan in 1996. Several VISA cases have been reported in the U. S. from patients on peritoneal dialysis. All patients had previous infections with MRSA, and had received vancomycin therapy. The first case of vancomycin resistant staphylococcus aureus was reported in 2002. In recent years MRSA outbreaks have been reported in children attending child care, inmates and men who have sex with men. During 2003, four outbreaks of Community-acquired MRSA were investigated in West Virginia. One outbreak occurred in state corrections and regional jails. Three other outbreaks occurred in close-knit family or social groups in locations widely scattered across West Virginia. Clinical DescriptionStaphylococcus aureus is a major cause of skin infections (e.g., cellulitis, boils, impetigo, etc), soft-tissue infections including abscesses, respiratory infections including pneumonia and sinusitis, bone, joint and endovascular infections (e.g., endocarditis, vascular graft infections, etc.). Serious infections include bacteremia, endocarditis, metastatic infections, sepsis and Staphylococcal toxic shock syndrome. Investigators should be certain they understand the difference between colonization and infection:
Etiologic AgentThe gram positive bacteria Staphylococcus aureus. ReservoirHumans, and rarely animals. Mode of TransmissionThe major site of colonization is the anterior nares; 20-30% of the general population are nasal carriers of coagulase-positive staphylococci. Autoinfection is responsible for at least one-third of infections. Persons with a draining lesion or any purulent discharge are the most common sources of epidemic spread. Transmission is through contact with a person who either has a purulent lesion or is an asymptomatic (usually nasal) carrier of a pathogenic strain. Some carriers are more effective disseminators of infection than others. The role of contaminated objects has been over stressed; the hands are the most important instrument for transmitting infection. Airborne spread is rare, but has been demonstrated in infants with associated viral respiratory disease. Incubation PeriodVariable and indefinite; commonly 4-10 days. Period of CommunicabilityAs long as purulent lesions continue to drain or the carrier state persists. Autoinfection may continue for the period of nasal colonization or duration of active lesions. Outbreak RecognitionSince no case of vancomycin intermediate or vancomycin resistant Staphylococcus aureus has ever been identified in West Virginia, one case is defined as an outbreak. In West Virginia, cases of community-acquired MRSA have to date only been identified in regional jails and correctional facilities in our state. Therefore, one community-acquired case is defined as an outbreak. WVDHHR is continuing to ask for reporting of MRSA cases in regional jails and corrections as part of an ongoing outbreak investigation. Other community-acquired cases should also be reported. In hospitals and health care facilities, an outbreak of MRSA is defined as the occurrence of MRSA cases above the normally expected rate. Clinical Description Staphylococcus aureus can produce a variety of syndromes with clinical manifestations including skin and soft tissue lesions, empyema, and pyarthrosis, bloodstream infections, pneumonia, osteomyelitis, septic arthritis, endocarditis, sepsis and meningitis. Laboratory Criteria for Diagnosis
Case Classification
Case definition for community acquired methicillin resistant Staphylococcus aureus infection (draft working case definition)Clinical Description Staphylococcus aureus can produce a variety of syndromes with clinical manifestations including skin and soft tissue lesions, empyema, and pyarthrosis, bloodstream infections, pneumonia, osteomyelitis, septic arthritis, endocarditis, sepsis and meningitis Laboratory Criteria
Epidemiological Criteria Absent history of hospital or nursing home stay in the year prior to onset. Case Classification
Expanded working case definition for outbreaks of possible community acquired methicillin resistant Staphylococcus aureus infection (draft working case definition) Clinical Description Staphylococcus aureus infection can produce a variety of syndromes with clinical manifestations including skin and soft tissue lesions, empyema, and pyarthrosis, bloodstream infections, pneumonia, osteomyelitis, septic arthritis, endocarditis, sepsis and meningitis. Staphylococcus aureus colonization is not associated with clinical signs of illness or inflammation.Laboratory Criteria
Epidemiological Criteria Absent history of hospital or nursing home stay in the year prior to onset. Case Classification A clinically compatible case that meets the epidemiological criteria and is epidemiologically-linked to a confirmed case. Confirmed (infection): A clinically compatible case of methicillin resistant Staphylococcus aureus that meets the epidemiological criteria and is laboratory confirmed. Confirmed (colonization): A case without clinical signs or symptoms that meets the epidemiological criteria and is laboratory confirmed. Preventive InterventionsHealth care facilities (hospitals, nursing homes, jails and DOC) should:
Preventing unnecessary antibiotic use is extremely important in the community as well. WVDHHR has developed physician and patient information sheets on appropriate management of pediatric upper respiratory infections. TreatmentFor treatment of serious Staphylococcus aureus infections, nafcillin has been the intravenous drug of choice and multiple effective oral antibiotics are available. Options are more limited with MRSA; vancomycin is the drug of choice for severe infections, although some strains are effectively treated with trimethoprim-sulfamethoxazole and other alternative agents. Vancomycin is more expensive, more toxic and more difficult to administer that the antistaphylococcal penicillins. Preferred regimens for Vancomycin intermediate or resistant staphylococcal infections are unknown, as there is yet little experience with these organisms. Surveillance Indicators
|
State
of West Virginia (WV) A-Z Listing of West Virginia's Reportable Diseases
|